Small · 2023 · 45 citations · 41 references
Life SciencesBioengineeringPharmacologyBiomaterialsDrug DeliveryNanomaterialsCell-nanoparticle InteractionsNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle CharacterizationNanoparticle DesignInflammatory Responses To NanoparticlesMitochondrial Targeting Of NanoparticlesMultifunctional NanoparticlesNanoparticle-based ProbesPyroptosis MechanismsReactive Oxygen Species GenerationReactive Oxygen Species InjuryReactive Oxygen Species-responsive Nanoparticles
Intervertebral disc degeneration (IVDD) is a significant contributor to low back pain, characterized by excessive reactive oxygen species generation and inflammation-induced pyroptosis. Unfortunately, there are currently no specific molecules or materials available to effectively delay IVDD. This study develops a multifunctional full name of PG@Cu nanoparticle network (PG@Cu). A designed pentapeptide, bonded on PG@Cu nanoparticles via a Schiff base bond, imparts multifunctionality to the metal polyphenol particles (PG@Cu-FP). PG@Cu-FP exhibits enhanced escape from lysosomal capture, enabling efficient targeting of mitochondria to scavenge excess reactive oxygen species. The scavenging activity against reactive oxygen species originates from the polyphenol-based structures within the nanoparticles. Furthermore, Pyroptosis is effectively blocked by inhibiting Gasdermin mediated pore formation and membrane rupture. PG@Cu-FP successfully reduces the activation of the nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 inflammasome by inhibiting Gasdermin protein family (Gasdermin D, GSDMD) oligomerization, leading to reduced expression of Nod-like receptors. This multifaceted approach demonstrates higher efficiency in inhibiting Pyroptosis. Experimental results confirm that PG@Cu-FP preserves disc height, retains water content, and preserves tissue structure. These findings highlight the potential of PG@Cu-FP in improving IVDD and provide novel insights for future research in IVDD treatments.
41
2D vanadium carbide MXenzyme to alleviate ROS-mediated inflammatory and neurodegenerative diseases
Wei Feng, Xiuguo Han, Hui Hu et al. · Nature Communications · 2021 · 499 citations · Full text
Hongyuan Xing, Zengjie Zhang, Qijiang Mao et al. · Journal of Nanobiotechnology · 2021 · 303 citations · Full text
Makarand V. Risbud, Zachary R. Schoepflin, Fackson Mwale et al. · Journal of Orthopaedic Research® · 2014 · 265 citations · Full text